Achievements, Collaborations, Innovation Celebrated at Inaugural Women Building Bio Event

Virginia Bio and Regional Life Sciences Community Convened to Build

RICHMOND, Va.–(BUSINESS WIRE)–#biotechVirginia
, the statewide non-profit association representing the life
science industry in the Commonwealth of Virginia, successfully hosted
its inaugural conference Women
Building Bio: The XX Factor
to celebrate the role of women in the
bioscience community, share strategies for driving collaboration in
research and commercialization, highlight tactics for developing
employees and leaders in the workplace and discuss the importance of
educating and encouraging female students to participate in STEM

Women Building Bio: The XX Factor, held on September 29 at the Inova
Center for Personalized Health, brought together 250 leaders from
enterprise life science companies and research institutions to
entrepreneurs, legislators and academias. This event marked the first
time women across the industry have come together from across Virginia
and the BioHealth Capital region to identify needs and opportunities,
make connections and continue driving excellence in bioscience.

“We are thrilled with the outcome of our first Women Building Bio
conference,” said Crystal Icenhour, CEO of Aperiomics and chairman for
Virginia Bio. “Women from across the region and in the industry are
proving that we are leading the way on creating stronger, healthier
communities due to the advancement of biosciences.”

Attendees of Women Building Bio participated in a variety of
thought-provoking sessions and panels delivered by industry leaders
including Todd Stottlemyer, CEO of Inova Center for Personalized Health;
Rachel King, CEO GlycoMimetics; Barbara Newhouse, president and CEO of
The ALS Association; Rep. Barbara Comstock; Amy Caro, sector vice
president and general manager, Health Division, Northrop Grumman
Information Systems; and Mindy Goldsborough, chief science and
technology Officer of American Type Culture Collection.

“Women Building Bio was a success because of the extraordinary talent
and resources we have in Virginia, Maryland and D.C.,” said Jeffrey
Gallagher, CEO of Virginia Bio. “To see over 250 attendees embrace
collaboration and innovation, regardless of their differences, to
continue building the most important industry of our time, was truly

Virginia Bio plans on continuing highlighting the themes of innovation,
celebration and collaboration at its upcoming events across the state,
including at the statewide conference THRIVE 2017, on April 6 at the
Hilton Virginia Beach Oceanfront.

About the Virginia Biotechnology Association

Virginia Bio is the premier statewide non-profit trade association for
life sciences, promoting the considerable scientific and economic impact
of the life sciences industry in the Commonwealth of Virginia. Virginia
Bio is an advocate for innovation and entrepreneurship, and for the
biopharmaceutical, and other health technology industries among federal,
state and local policy-makers. Virginia Bio is the official state
affiliate of the Biotechnology Industry Organization (BIO), AdvaMed and
the Medical Device Manufacturers Association (MDMA) and also
collaborates closely with the Pharmaceutical Research and Manufacturers
of America (PhRMA). To learn more, visit
or Follow Virginia Bio on Twitter at @VABio.


Women Building Bio: The XX Factor was made possible by Inova, George
Mason University, Darden Executive Education, Greenberg Traurig, PhRMA,
Virginia Economic Development Partnership, Squire Patton Boggs, Pfizer,
Xenith, Prince William County, HHMI Janelia Research Campus, Cherry
Bekaert, Merck, George Washington University, AstraZeneca/MedImmune,
Silverline Communications, Loudoun Virginia Economic Development,
Northrop Grumman, Illumina, New England Lab, Embody, Avison Young,
Virginia Biotechnology Research Park, Euclid, Polymer Solutions and
James Madison University.


Silverline Communications
Tori Montano, 202-765-2803